Pharmtech & Ingredients 2018: a presentation of achievements of the pharmaceutical industry and dozens of business contacts
Pharmtech & Ingredients 2018 is one of the largest exhibitions of Russia and near-abroad countries which has been opened today in Moscow at the Crocus Expo exhibition center.
More than 460 manufacturers and suppliers of the pharmaceutical industry from 30 countries of the world are presenting their products at the international exhibition Pharmtech & Ingredients 2018 in Moscow. For the first time within the exhibition, the collective exposition of Indian companies and the collective exposition of Chinese API manufacturers are presented.
The Director of FSI «SID & GP» of Minpromtorg of Russia Mr. Vladislav Shestakov took part in the official opening ceremony of this international event. In his welcome address, the Deputy Head of the Russian GMP-Inspectorate highlighted the role of innovations in the pharmaceutical industry.
«This is a unique platform for presenting the forefront of the modern science and manufacture, breakthrough technologies – everything which defines the today’s vector of pharmaceutical industry development. And for all of us, this is a unique chance to see all of that in one place. For those who participate in the event for the first time, it is an excellent opportunity to become a name in the Russian market. As for the companies long being in the RF and EAEU markets, it is a wonderful occasion to once again confirm their status and demonstrate to colleagues, customers, and partners their success in growth and R&D achievements», said the Director of FSI «SID & GP» of Minpromtorg of Russia, the Deputy Head of the Russian GMP-inspectorate Mr. Vladislav Shestakov.
The first day of the event was dedicated to the official visit of the international exhibition of equipment, raw materials, and technologies for pharmaceutical manufacture «PharmTech-2018» with participation of the Director of the Department of Pharmaceutical and Medical Industry Development Mr. Aleksey Alekhin, the Director of FSI «SID & GP» of Minpromtorg of Russia Mr. Vladislav Shestakov, the General Director of the Association of Russian Pharmaceutical Manufacturers Mr. Viktor Dmitriev, the Executive Director of the Union of Professional Pharmaceutical Organizations Ms. Liliya Titova, and other reputable experts of the industry.
The representatives of FSI «SID & GP» attended the round table discussion on the topic «The era of digitalization and data integrity. The view of the industry» organized by the PharmaPharm industry portal. Members of the round table discussion outlined the main trends in digitalization, automation, and quality assurance in pharmaceutical manufacture.
«It is a known fact that the majority of data in the industry is paper-based», said the Head of Good Engineering Practice Department of FSI «SID & GP» Mr. Igor Falkovskiy. «But even paper-based documents should comply with GMP requirements and have a unique identification number. It also necessary to trace that effective versions of paper-based documents are used. If a computerized system is used, it automatically takes many issues off the table.»
Besides, the experts of FSI «SID & GP» took part in the round table discussion on the topic «Technology transfer: the best practices of Russian and foreign manufacturers». Its participants discussed the topical issues of technology transfer upon localization and scaling-up of pharmaceutical manufacture.
At their display booths, the participants are demonstrating a large variety of manufacturing and packaging equipment, laboratory equipment, design and technology solutions for turn-key pharmaceutical manufacture, clinical trials, «clean rooms», pharmaceutical logistics. The Ingredients section reflects an increasing role of high-quality APIs and functional ingredients in manufacture of modern drugs.
The exhibition will see more than 20 events of the business agenda attended by the leading experts in pharmaceutical manufacture, representatives of state regulation authorities, and top managers of Russian and foreign companies.